The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
GlobalData on MSN
Centivax begins participant dosing in Phase Ia flu vaccine trial
Initial data from 180 participants are anticipated within the year.
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...
The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.
Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused ...
By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
The 2024-2025 flu season resulted in 266 pediatric deaths, with 90% of the children who died being eligible for a flu vaccine ...
FDA refuses Moderna's mRNA flu vaccine application, citing inadequate study design, as the company disputes decision, saying it contradicts prior FDA guidance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results